Procept BioRobotics outlines $390M-$410M 2026 revenue target
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: PROCEPT BioRobotics (PRCT) Q3 2026 MANAGEMENT VIEW * “This quarter… delivered total revenue of $98.3 million, reflecting 18% year-over-year growth” and “completed over 13,400 U.S. procedures… growing 22% year-over-year, led by our HYDROS accounts”…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishQ3 revenue growth and a target of positive adjusted EBITDA in Q4 are relevant for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 revenue was $98.3 million, up 18% year over year.
- 02U.S. procedures grew 22% year over year.
- 03The company placed 62 HYDROS systems in the quarter.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets